American Healthcare REIT (NYSE:AHR) Price Target Raised to $71.00

Posted by Geri Gentry on Nov 11th, 2026

American Healthcare REIT (NYSE:AHR – Get Free Report) had its price target boosted by UBS Group from $62.00 to $71.00 in a report released on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group‘s price target points to a potential upside of 19.89% from the company’s current price.

Other research analysts have also recently issued reports about the stock. Weiss Ratings raised shares of American Healthcare REIT from a “hold (c+)” rating to a “buy (b)” rating in a report on Monday. KeyCorp raised their target price on shares of American Healthcare REIT from $58.00 to $68.00 and gave the stock an “overweight” rating in a report on Wednesday, August 19th. Compass Point assumed coverage on shares of American Healthcare REIT in a research report on Tuesday, July 21st. They issued a “buy” rating and a $70.00 target price for the company. Truist Financial boosted their target price on shares of American Healthcare REIT from $57.00 to $61.00 and gave the company a “buy” rating in a research note on Friday, August 14th. Finally, Raymond James Financial reiterated a “strong-buy” rating and set a $72.00 target price on shares of American Healthcare REIT in a research note on Tuesday. Two equities research analysts have rated the stock with a Strong Buy rating and thirteen have given a Buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $64.00.

Get Our Latest Stock Report on American Healthcare REIT

American Healthcare REIT Stock Performance

NYSE:AHR traded down $0.17 during mid-day trading on Wednesday, reaching $59.22. The company’s stock had a trading volume of 1,400,236 shares, compared to its average volume of 3,001,972. American Healthcare REIT has a 12-month low of $44.81 and a 12-month high of $59.55. The firm’s fifty day moving average price is $53.24 and its two-hundred day moving average price is $51.76. The company has a current ratio of 0.53, a quick ratio of 0.48 and a debt-to-equity ratio of 0.15. The stock has a market cap of $12.91 billion, a P/E ratio of 120.86, a PEG ratio of 1.40 and a beta of 0.78.

American Healthcare REIT (NYSE:AHR – Get Free Report) last posted its earnings results on Thursday, November 5th. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.02. The business had revenue of $742.15 million for the quarter, compared to analysts’ expectations of $703.51 million. American Healthcare REIT had a net margin of 3.61% and a return on equity of 2.38%. The business’s revenue for the quarter was up 29.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.44 EPS. On average, equities analysts forecast that American Healthcare REIT will post 2.25 EPS for the current fiscal year.

Insider Transactions at American Healthcare REIT

In other news, EVP Mark E. Foster sold 1,500 shares of the stock in a transaction that occurred on Friday, September 25th. The shares were sold at an average price of $52.06, for a total value of $78,090.00. Following the transaction, the executive vice president owned 50,117 shares in the company, valued at $2,609,091.02. This represents a 2.91% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Scott A. Estes sold 2,500 shares of the stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $59.32, for a total transaction of $148,300.00. Following the completion of the transaction, the director owned 18,989 shares in the company, valued at $1,126,427.48. This trade represents a 11.63% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 6,000 shares of company stock valued at $337,170. Corporate insiders own 0.75% of the company’s stock.

Institutional Trading of American Healthcare REIT

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Advisors Asset Management Inc. bought a new position in American Healthcare REIT in the third quarter worth approximately $337,000. Private Advisor Group LLC boosted its stake in shares of American Healthcare REIT by 15.7% during the 3rd quarter. Private Advisor Group LLC now owns 32,586 shares of the company’s stock worth $1,670,000 after acquiring an additional 4,431 shares during the last quarter. Ieq Capital LLC purchased a new position in shares of American Healthcare REIT during the 3rd quarter worth $206,000. Landscape Capital Management L.L.C. bought a new stake in shares of American Healthcare REIT during the 3rd quarter valued at $6,831,000. Finally, Composition Wealth LLC grew its position in shares of American Healthcare REIT by 5.0% during the 3rd quarter. Composition Wealth LLC now owns 4,662 shares of the company’s stock valued at $239,000 after acquiring an additional 224 shares during the period. 16.68% of the stock is owned by hedge funds and other institutional investors.

American Healthcare REIT Company Profile

(Get Free Report)

American Healthcare REIT is a real estate investment trust focused on healthcare-related properties. Its portfolio includes senior housing and care communities, skilled nursing facilities, outpatient medical buildings, and integrated senior health campuses. The company owns and operates properties across the United States and the United Kingdom. Its facilities support a range of healthcare and senior living services, including assisted living, memory care, and post-acute care. American Healthcare REIT began trading on the New York Stock Exchange in 2024.